Related Experiment Video

Updated: Jul 17, 2026

A Preliminary Study on Warm Acupuncture and Moxibustion for Treating Chronic Obstructive Pulmonary Disease with Abdominal Distension
05:19

A Preliminary Study on Warm Acupuncture and Moxibustion for Treating Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

Bronchiolitis

Rosalind L Smyth1, Peter J M Openshaw

  • 1Division of Child Health, School of Reproductive and Developmental Medicine, University of Liverpool, Alder Hey Children's Hospital, Liverpool L12 2AP, UK. r.l.smyth@liv.ac.uk

Lancet (London, England)
|July 25, 2006
PubMed

Insights

Bronchiolitis, a common infant respiratory illness often caused by respiratory syncytial virus, presents a significant clinical challenge. Further research into its causes and inflammatory pathways is crucial for developing effective treatments.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Bronchiolitis is a common, potentially severe respiratory illness affecting infants, frequently caused by respiratory syncytial virus (RSV).
  • Hospitalization rates are significant, with affected infants experiencing intense airway inflammation and an increased risk of recurrent wheezing.
  • Despite its prevalence, the underlying causes of infant susceptibility and effective treatments remain poorly understood.

Purpose of the Study:

  • To highlight the clinical challenges and research needs associated with infant bronchiolitis.
  • To emphasize the need for improved diagnostic criteria and the development of targeted therapies.

Main Methods:

  • Review of current understanding of bronchiolitis pathogenesis and clinical management.
  • Identification of research gaps in susceptibility factors and treatment strategies.

Main Results:

  • Bronchiolitis affects 2-3% of infants under one year, often requiring hospitalization during seasonal epidemics.
  • Current diagnostic tools and supportive care have limited impact on clinical outcomes.
  • Inflammatory pathways in bronchiolitis pathogenesis are not fully elucidated.

Conclusions:

  • Bronchiolitis poses a significant clinical conundrum requiring further research.
  • High-quality clinical studies are essential for refining disease severity assessment and hospital admission criteria.
  • Mapping inflammatory pathways is key to developing novel therapeutic interventions for bronchiolitis.

More Related Videos

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease03:25

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease

Published on: December 27, 2024

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...